QR-333: Phase IIb data

Quigley Corp. (NASDAQ:QGLY), Doylestown, Pa. Product: QR-333 Business: Neurology Molecular target: Aldose reductase Description: Topical formulation of quercetin, ascorbyl palmitate and vitamin D3 In...